搜索筛选:
搜索耗时0.0809秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[会议论文] 作者:Zhiguo Zhang,Tingting Liu,Dawei Chen,Weiwei Zou,Dongmei Ji,Beili Chen,Yan Hao,Ping Zhou,Yunxia Cao, 来源:中华医学会第十次全国生殖医学学术会议 年份:2016
[会议论文] 作者:Dan Han,Zhiguo Zhang,Yan Hao,Dawei Chen,Mingrong Lv,Fuxi Zhu,Weiwei Zou,Dongmei Ji,Yunxia Cao,Ping Zhou, 来源:中华医学会第九次全国生殖医学学术会议 年份:2015
[期刊论文] 作者:Ya\'nan Yang,Chenchen Wang,Congqi Dai,Xinyang Liu,Wenhua Li,Mingzhu Huang,Xiaoying Zhao,Dongmei Ji,Jin, 来源:生物化学与生物物理学报(英文版) 年份:2021
The prognostic significance of c-MET in gastric cancer(GC)remains uncertain.In the present study,we examined the amplification,expression,and the prognostic val...
[期刊论文] 作者:Lin Gui,Junning Cao,Dongmei Ji,Huilai Zhang,Qian Fan,Jun Zhu,Yuqin Song,Shiyu Jiang,Zhiqiang Ning,Jia, 来源:中国癌症研究(英文版) 年份:2021
Objective:Chidamide is an oral histone deacetylase subtype-selective inhibitor approved for relapsed or refractory peripheral T-cell lymphoma (PTCL).This phase 1b study evaluated the safety,pharmacokinetics,and preliminary efficacy of chida......
[会议论文] 作者:Zhe Zhang,Dongmei Ji,Chenchen Wang,Rujiao Liu,Zheng Wu,Lian Liu,Dan Zhu,Jinjia Chang,Jin Li,Jiping Wang, 来源:第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份:2013
[会议论文] 作者:Zhe Zhang,Jiping Wang,Dongmei Ji,Chenchen Wang,Rujiao Liu,Zheng Wu,Lian Liu,Dan Zhu,Jinjia Chang,Lei, 来源:第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份:2013
目的: Elucidating the molecular mechanism of primary or acquired drug resistance can be critical to identify patients who fail to respond to therapy, and may help design more efficient treatment protoco...
[会议论文] 作者:Nong Xu,Ying Cheng,Zhehai Wang,Leizhen Zheng,Min Tao,xiaodong Zhu,Dongmei Ji,Xin Liu,weijian Guo,Jianping, 来源:第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 年份:2012
[会议论文] 作者:Jin Li,Nong Xu,Ying Cheng,Zhehai Wang,Leizhen Zheng,Min Tao,xiaodong Zhu,Dongmei Ji,Xin Liu,Shukui Qin, 来源:第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 年份:2012
相关搜索: